Castle Biosciences Files 8-K on Security Holder Rights & Corporate Actions
Ticker: CSTL · Form: 8-K · Filed: May 23, 2025 · CIK: 1447362
| Field | Detail |
|---|---|
| Company | Castle Biosciences Inc (CSTL) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, shareholder-rights
TL;DR
Castle Biosciences filed an 8-K detailing changes to security holder rights and corporate governance matters.
AI Summary
On May 22, 2025, Castle Biosciences, Inc. filed an 8-K report detailing several key events. These include material modifications to the rights of security holders, amendments to its articles of incorporation or bylaws, and the submission of matters to a vote of security holders. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates significant corporate governance and potential changes affecting shareholder rights and company structure, requiring investor attention.
Risk Assessment
Risk Level: medium — The filing involves changes to security holder rights and corporate governance, which can introduce uncertainty and impact shareholder value.
Key Numbers
- 001-38984 — SEC File Number (Identifies the company's filing history with the SEC.)
- 77-0701774 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Castle Biosciences, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 505 S. Friendswood Drive, Suite 401, Friendswood, Texas 77546 (address) — Principal executive offices
FAQ
What specific modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the summary text.
What were the key amendments to Castle Biosciences' articles of incorporation or bylaws?
The filing states that amendments to the articles of incorporation or bylaws were made, but the specific nature of these amendments is not detailed in the provided text.
What matters were submitted to a vote of security holders?
The report confirms that matters were submitted to a vote of security holders, but the specific proposals or resolutions are not outlined in the summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 22, 2025.
Where are Castle Biosciences' principal executive offices located?
Castle Biosciences, Inc.'s principal executive offices are located at 505 S. Friendswood Drive, Suite 401, Friendswood, Texas 77546.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding CASTLE BIOSCIENCES INC (CSTL).